Hamdy R C, Vinson M E, Robbins A D, Struthers L P, Chapman S F, Norris R J, Shaw H L
Curr Med Res Opin. 1984;9(2):124-31. doi: 10.1185/03007998409109570.
Urinary volume and electrolyte excretion were monitored for 24 hours in 12 elderly, catheterized patients with mild congestive cardiac failure. Five timed collections (0 to 3, 3 to 6, 6 to 9, 9 to 12 and 12 to 24 hours) were made after single doses of 40 mg frusemide, 5 mg amiloride and a combination tablet containing both 40 mg frusemide and 5 mg amiloride. Patients received each therapy according to a Latin Square design, with a 6-day washout phase separating the three study periods. The study periods consisted of a 24-hour control urinary collection, immediately followed by diuretic and a further 24-hour urine collection. Diuretics were not administered immediately prior to the study or during the washout phases. Amiloride, as expected, showed mild diuretic and natriuretic properties, but in the 12 to 24-hour period it induced a greater diuresis (p less than 0.05) than did frusemide or the combination. Frusemide and the combination tablet both produced a rapid and powerful diuresis in the 0 to 3-hour post-dose period and did not differ significantly in urine output at any time point. However, a difference in natriuretic activity was seen between frusemide and the combination, with the latter producing a significantly greater sodium excretion in the 12 to 24-hour period (p less than 0.05). Potassium-retaining activity throughout the 24 hours was marked after amiloride, with potassium excretion being significantly less (p less than 0.05) than either control, frusemide or the combination.(ABSTRACT TRUNCATED AT 250 WORDS)
对12例轻度充血性心力衰竭的老年导尿患者进行了24小时尿量和电解质排泄监测。在单次给予40毫克速尿、5毫克阿米洛利以及含有40毫克速尿和5毫克阿米洛利的复方片剂后,进行了五次定时收集(0至3小时、3至6小时、6至9小时、9至12小时和12至24小时)。患者按照拉丁方设计接受每种治疗,三个研究阶段之间有6天的洗脱期。研究阶段包括24小时对照尿收集,紧接着给予利尿剂并进一步进行24小时尿收集。在研究前或洗脱期不立即给予利尿剂。正如预期的那样,阿米洛利显示出轻度利尿和利钠特性,但在12至24小时期间,它引起的利尿作用(p小于0.05)比速尿或复方制剂更大。速尿和复方片剂在给药后0至3小时均产生快速而强大的利尿作用,在任何时间点的尿量上没有显著差异。然而,可以观察到速尿和复方制剂在利钠活性上存在差异,后者在12至24小时期间产生的钠排泄显著更多(p小于0.05)。在服用阿米洛利后,24小时内的保钾活性明显,钾排泄量显著低于对照组、速尿或复方制剂(p小于0.05)。(摘要截短至250字)